Table 2.
Evaluated characteristics at consecutive follow-up visits (n = 23)
| Variable | Baseline | Day 1 | Day 7 | Month 1 | Month 3 | Month 6 |
|---|---|---|---|---|---|---|
| Eyes, n | 23 | 23 | 23 | 23 | 23 | 23 |
| IOP x̄ ± SD (mm Hg) | 20.3 ± 5.9 | 14.5 ± 5.2 | 13.1 ± 6.9 | 13.8 ± 4.2 | 14.3 ± 3.1 | 14.4 ± 3.9 |
| IOP median (IQR), (mm Hg) | 20 (16–24) | 15 (12–16) | 13 (10–16) | 14 (11–16) | 14 (12–17) | 15 (12–16) |
| IOP reduction, % | – | 24.9 | 31.4 | 28.3 | 25.3 | 25.6 |
| Eyes with a >20% IOP reduction, % | – | 52.1 | 69.5 | 69.5 | 62.2 | 62.2 |
| Complete success, % | – | – | – | 47.8 | 52.2 | 30.4 |
| Number of glaucoma medications, x̄ ± SD | 2.7 ± 1.5 | – | – | 1.0 ± 1.2 | 1.0 ± 1.2 | 1.2 ± 1.0 |
x̄, mean; SD, standard deviation; IQR, interquartile range; IOP, intraocular pressure